Aurolab Hydrophobic Foldable Intraocular Lens Study
Launched by AUROLAB · Mar 19, 2007
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Hydrophobic as the name suggests is fear for water. Hydrophobic foldable IOLs are made from acrylic material. Aurolab has developed its own hydrophobic acrylic material. This material has been subjected to several biocompatibility studies and it has proved itself to be biocompatible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 40 to 65 years
- • Senile Cataract
- • Posterior Subcapsular Cataract (PSCC)
- Exclusion Criteria:
- • Obviously debilitated patients
- • Cardiac and other serious illness
- • Diabetic Patients
- • Traumatic cataract
- • Complicated cataract
- • Congenital cataract
- • Drug induced cataract
- • Shallow anterior chamber
- • Poor mydriasis
- • Amblyopia
- • Pseudo exfoliation (PXF)
- • Dense posterior polar cataract (PPC)
- • One eyed patients
- • Glaucoma
- • Uveitis
- • Corneal Pathology
- • Retinal Pathology
- • Intra operative complications like PC rupture, Zonular dialysis
About Aurolab
Aurolab is a leading global organization dedicated to advancing eye care through the development and manufacturing of innovative medical devices and pharmaceuticals. Based in India, Aurolab specializes in producing high-quality ophthalmic products, including intraocular lenses and surgical instruments, aimed at improving patient outcomes and accessibility to eye care solutions. Committed to research and development, Aurolab actively sponsors clinical trials to evaluate the safety and efficacy of its products, ensuring compliance with international standards and contributing to the global fight against blindness. Through collaboration with healthcare professionals and institutions, Aurolab strives to enhance vision health and promote sustainable eye care practices worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madurai, Tamil Nadu, India
Patients applied
Trial Officials
Haripriya Aravind, MBBS, MS
Principal Investigator
Aravind Eye Hospital, Madurai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials